Baxter International | BAX - Pe Kurs-Gewinn

Aktienkurs
17.78
Täglich Wechseln
0.47 2.72%
Monatlich
1.02%
Jährlich
-42.72%
Q2 Prognose
17.62




Pe Veränderung Datum
Abbott 24.94 5.78 2026-03
AngioDynamics 8.82 1.6 2024-03
Artivion 212.38 16.51 2025-12
AtriCure 34.15 2.7 2022-06
Avanos Medical 18.02 108.8 2026-03
Baxter International 86 68.9 2025-12
Becton, Dickinson and Co. 17.68 114.67 2025-12
Boston Scientific 32.35 5.17 2026-03
Cooper Companies 40.27 15.78 2025-12
Dexcom 24.73 7.45 2026-03
Edwards Lifesciences 26.86 4.76 2026-03
Fresenius 15.18 0.63 2025-12
Globus Medical 35.3 10.24 2026-03
Halozyme Therapeutics 11.35 11.8 2026-03
ICU Medical 158.3 38.83 2025-12
Inogen 69.33 30.67 2021-09
Insulet 38.83 16.24 2026-03
Integra LifeSciences 5.07 1.52 2026-03
Intuitive Surgical 55.82 15.79 2026-03
J&J 24.53 0.91 2026-03
Laboratory Of America 25.51 4.65 2026-03
Masimo 43.54 11.1 2026-03
Medtronic 22.76 1.32 2025-12
Merit Medical Systems 45.2 6.08 2025-12
Quest Diagnostics 22.4 2.63 2026-03
Smith & Nephew 17.63 4.2 2025-12
Stryker 30.44 1.69 2026-03
Tandem Diabetes Care 681.05 189.32 2022-03
Teleflex 49.25 21.46 2026-03
Terumo 23.28 2.98 2025-09
Zimmer Biomet Holdings 25.47 7.56 2026-03